View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML

HHS/CMS RIN: 0938-AU25 Publication ID: Spring 2020 
Title: ●Request for Information; Electronic Prescribing for Controlled Substances (CMS-3394) 

This Request for Information (RFI) seeks input from stakeholders on the most effective way to implement section 2003 of the SUPPORT for Patients and Communities Act (SUPPORT Act).  The SUPPORT Act requires that a Schedule II, III, IV, or V controlled substance covered under a Medicare Part D prescription drug plan or Medicare Advantage Prescription Drug Plan (MA/PD) be transmitted in accordance with an electronic prescription drug program beginning January 1, 2021, including when the requirement for Electronic Prescribing for Controlled Substances (EPCS) should be waived, and what (if any) penalties should be imposed on prescribers who do not use EPCS.

Agency: Department of Health and Human Services(HHS)  Priority: Other Significant 
RIN Status: First time published in the Unified Agenda Agenda Stage of Rulemaking: Prerule Stage 
Major: No  Unfunded Mandates: No 
EO 13771 Designation: Other 
CFR Citation: None     (To search for a specific CFR, visit the Code of Federal Regulations.)
Legal Authority: Pub. L. 115-271, sec. 2003   
Legal Deadline:  None
Action Date FR Cite
Notice With Comment  06/00/2020 
Regulatory Flexibility Analysis Required: No  Government Levels Affected: Federal 
Federalism: No 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: No 
Agency Contact:
Dan Herrmann
Health Insurance Specialist
Department of Health and Human Services
Centers for Medicare & Medicaid Services
Center for Clinical Standards and Quality, MS: S3-02-01, 7500 Security Boulevard,
Baltimore, MD 21244
Phone:410 786-7827